IMUX
Immunic Inc
10.60$
+2.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.2% | +36.1% | -44.8% | -27.2% | -93.1% | -22.0% | +117.9% | -9.4% | +44.2% | +20.7% | +25.4% | |
| – | +60.5% | +16.1% | +17.1% | -31.8% | +74.3% | -57.8% | +116.6% | +33.3% | -10.4% | +20.1% | +3.9% | |
| – | +59.2% | +18.2% | +20.4% | -9.5% | +48.3% | -97.2% | +8,532.9% | +141.5% | – | – | – | |
| – | -156.4% | – | – | -253.7% | – | – | – | – | +57.9% | -96.3% | +225.9% | |
| – | +66.1% | -76.2% | +23.2% | -12.8% | -90.8% | +165.5% | -54.1% | +67.2% | +198.2% | -21.0% | -39.0% | |
| – | -37.2% | -98.4% | +3,128.6% | -38.8% | – | -101.4% | -54.1% | +14,438.8% | – | -102.8% | -39.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -69.7% | -61.8% | +207.0% | -100.0% | +872,275.0% | +313.9% | -99.9% | +97.8% | -29.1% | -40.3% | +136.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -69.7% | -61.8% | +207.0% | -100.0% | +872,275.0% | +313.9% | -70.3% | +123.5% | -98.9% | +7,116.0% | -12.0% | |
| – | -129.4% | – | – | – | – | +501.8% | -141.4% | – | -402.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.